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Sir, 
Autoinflammatory syndromes are caused by an exaggerated innate immune system 
response and can pose important diagnostic challenges. They are often diagnosed by a 
combination of clinical findings and genetic testing. First presentation is often in childhood, 
although 10% of patients develop their first symptoms after the age of 301.   
Herein we report a complex case with heterozygosity for MEFV with atypical Adult Onset 
Still’s Disease (AOSD) in a 39-year-old Colombian woman, in her 3rd pregnancy trimester. At 
33 weeks gestation, she presented with a sore throat, polyarthralgia, myalgia and pleuritic 
chest pains. She had an erythematous maculopapular rash thought to be pregnancy-related 
pruritic eruption. Earlier in pregnancy she had developed biopsy-confirmed reactive axillary 
lymphadenopathy. Past surgery included breast augmentation and bariatric surgery; family 
history unremarkable. Clinically she was tachycardic with wrist, metacarpophalangeal and 
proximal interphalangeal joint synovitis. She had bilateral pitting leg oedema which 
gradually spread to the abdomen, associated with worsening hypoalbuminaemia. 
Inflammatory markers were raised; CRP 102mg/L, ESR60 mm/hr; white cell differential, 
ANA, ANCA, rheumatoid factor/anti-CCP and complement levels were all normal. Chest X-
ray showed unilateral consolidation. She was commenced on prednisolone for suspected 
reactive arthritis with broad spectrum antibiotic cover. After a brief clinical improvement, 
she deteriorated, continuing to remain afebrile. Emergency caesarean section was 
performed at 34 weeks due to concerns over maternofetal wellbeing. 
On day 3 post caesarean section she became febrile with worsening chest and joint pain. 
Abdominopelvic and chest CT and echocardiograph were normal. Colchicine was trialed 
unsuccessfully. Antibiotics were withdrawn after persistently negative microbiology tests 
with fever settling on day 6.  She continued to deteriorate clinically with myalgia, arthralgia, 
abdominal and pleuritic chest pains. At this point, the possibility of an autoinflammatory 
syndrome +/- atypical AOSD was considered due to a raised ferritin (5154 μg/L) and CRP 
(300mg/L). After multidisciplinary discussion, intravenous methylprednisolone 1g/d was 
commenced for 3 days, along with intravenous immunoglobulins for 5 days. This regimen 
was successful with a dramatic improvement in her inflammatory markers (Figure 1) and 
clinical picture. Further investigations revealed raised serum amyloid A (703mg/L) and 
genetic testing confirmed the presence of MEFV I591T.The patient was discharged home 
and remains stable at 1-year follow-up on colchicine, azathioprine, and hydroxychloroquine. 
FMF is the most common autoinflammatory syndrome resulting from mutations in the 
MEFV gene that encodes the protein pyrin which is involved in the regulation of 
inflammation and apoptosis; mutations lead to inflammation characterised by excessive 
Interleukin (IL)-1 secretion2. Initially, five mutations (V726A, M694V, M694I, M680I and 
E148Q) were identified which account for 74% of all cases3.  
However, a number of other mutations have since been identified with their significance 
often unknown. Rare mutations are preferentially found in populations not normally 
associated with the disease. This includes I591T on exon 9, described in a patient from 
France3, and a Spanish family4 and associated with FMF both in conjunction with a second 
mutation and as the sole genetic abnormality. One hypothesis, for other MEFV genes being 
identified is that they may be involved in non-FMF conditions5. 
Incidence is highest in populations around the Mediterranean but there are reported cases 
in Asia and South America. Classically, patients experience recurrent self-limiting episodes of 
fever and serositis. Pleural involvement occurs in 15% and is usually unilateral2. The trigger 
to these events can be physical/emotional stress resulting in an intense acute phase 
reaction2. Use of IL-1 receptor antagonists shows promise in patients who are intolerant to 
colchicine. AA amyloidosis and renal failure are serious complications if untreated.  
AOSD is also considered an autoinflammatory disorder. Diagnosis is made clinically and 
relies on the classical triad of daily spiking fevers, polyarthritis and a salmon-pink 
evanescent rash. Other manifestations include a prodromal sore throat, myalgia, weight 
loss, serositis, lymphadenopathy, hepatomegaly and macrophage activation syndrome. 
Laboratory findings include raised inflammatory markers, normocytic anaemia, 
hypoalbuminaemia, and raised serum ferritin in 50% of cases. FMF-related MEFV variants 
are implicated with the disease phenotype of AOSD6. 
This case is an example of a challenging autoinflammatory syndrome occurring in pregnancy 
in a patient of Hispanic ethnicity, heterozygote for an MEFV mutation and with no family 
history. Her clinical disease was not diagnostic of either FMF by the Tel-Hashomer criteria7 
nor AOSD. Nonetheless some of the clinical/biochemical manifestations, particularly the 
high ferritin are much more consistent with AOSD than FMF. She responded well to 
methylprednisolone and has been well as an outpatient on broad spectrum 
immunosuppression and colchicine. Colchicine is very effective prophylaxis in FMF and has 
been reported to be beneficial in patients with disease associated with heterozygous 
carriage of MEVF I591T8. Furthermore, a Japanese study suggested that MEFV variants 
(excluding the very common polymorphism E148Q) are over-represented in ASOD and are 
associated with recurrent or severe inflammation and an increased requirement for 
biologics6. We hope that prophylactic colchicine will ameliorate any pro-inflammatory 
contribution from the variant pyrin. This case highlights the diagnostic dilemmas that can be 
associated with adult-onset autoinflammatory syndromes, as well as the importance of 
multi-disciplinary team input and coordinated care. Further exploration of MEFV I591T is 
required to evaluate its contribution to this patient’s auto-inflammatory disease. 
Figure 1: Relationship between inflammatory response and treatment. 
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